FDA Approves New Drug Doubling Survival for Breast Cancer

A groundbreaking treatment for triple-negative breast cancer just got FDA approval, giving patients twice as long with controlled disease and six more months of life.

Christina, who could barely walk months ago, just walked down the aisle at a wedding thanks to this drug.